ANALISIS KESESUAIAN BIAYA RIIL PASIEN KANKER PAYUDARA PESERTA JKN NON-PBI DENGAN TARIF INA-CBG’s DI RSUP PROF DR KANDOU MANADO

Authors

  • Fridly Manawan Universitas Trinita
  • Mitra Wynne Timburas Universitas Trinita

DOI:

https://doi.org/10.35799/pha.11.2022.40472

Keywords:

Breast Cancer, INA-CBG’s, JKN Non-PBI

Abstract

Number of cancer incident in Indonesia exactly in second place that adsorbs state expenditure after hemodialysis included breast cancer. This study aims to find out the suitability of real cost and tariff INA-CBG’s the breast cancer inpatient whom became a member of National Health Insurance (JKN) Non-PBI breast cancer inpatient in RSUP Prof Kandou Manado. The research was an observational study with a cross-sectional design. Data retrospectively collected from medical record inpatient whom registered as a member of National Health Insurance (JKN) Non-PBI during September 2017-August 2018 period and from financial department of RSUP Prof Kandou Manado. Calculating the difference in total real costs with the total tariff of INA-CBG's package in JKN Non-PBI inpatients for breast cancer. The result of the study showed that the cost difference between total real cost and total tariff INA-CBG’s package in chemotherapy patient with C-14-3 code was Rp. 374.645.738, treatment in breast procedure with L-1-50 code was Rp. 496.325.510, and treatment for breast tumor with L-4-11 code was Rp. 294.784.926. The difference value between the real cost and tariff INA-CBG’s package was Rp. 1.165.756.174 for 130 breast cancer patient.

References

Aisyah, N. 2018. Analisis Biaya Kemoterapi Pada Pasien Rawat Inap Kanker Payudara Peserta JKN di RSUD Ulin Banjarmasin [Tesis]. Yogyakarta: Fakultas Farmasi, Universitas Gadjah Mada.

American cancer society. 2017. Breast cancer. Atlanta, Ga: American cancer society; 2017

Anonim., 2016. Peraturan Menteri Kesehatan Nomor 52 Tahun 2016 Tentang Standar Tarif Pelayanan Kesehatan dalam Penyelenggaraan Program Jaminan Kesehatan. Menteri Kesehatan Republik Indonesia, Jakarta.

Kemenkes. 2016. Bulan Peduli Kanker Payudara. Pusat Data dan Informasi Kementerian Kesehatan RI (Infodatin). 2446-7659.

Kemenkes. 2017. Pedoman Nasional Pelayanan Kedokteran: Kanker Payudara. Komite Penanggulangan Kanker Nasional: Kemenkes RI.

Purnamasari V, Andayani TM, Fudholi A. 2015. Analisis biaya terapi pada pasien Kanker Payudara dengan terapi Hormon di RSUP Dr. Wahidin Sudirohusodo Makassar Sulawesi Selatan. Jurnal Manajemen dan Pelayanan Farmasi 5(1):1-7

Sari, TH. 2017. Hubungan antara self compassion dan regulasi emosi dengan stres pada pasien kanker payudara pasca operasi yang sedang menjalani kemoterapi di rsu. Dadi keluarga purwokerto [Tesis]. Purwokerto: Fakultas Psikologi, Universitas Muhammadiyah Purwokerto.

Harianto, Andayani TM, Herowati R. 2015. Komparasi Biaya Riil Dengan Tarif INA CBGs dan Analisis Faktor yang Mempengaruhi Biaya Riil Kemoterapi Pada Pasien Kanker Payudara Rawat Inap Jamkesmas di RSUP Dr Sardjito Yogyakarta. dalam: Prosiding Seminar Fakultas Farmasi Universitas Setia Budi dipresentasikan pada Seminar Farmasi, 11 April 2015 07:02. Surakarta: 1/1.

Manawan, Fridly. 2019. Cost of Illnes Pasien Kanker Payudara di Rumah Sakit Umum Prof DR R.D Kandou Manado [Tesis]. Surakarta: Fakultas Farmasi, Universitas Setia Budi Surakarta.

Thabrany, H. 2011. Diskusi Penatalaksanaan dan Pembiayaan Kanker di Indonesia ; FKM-UI dan Roche Indonesia. Jakarta, 11 Mei 2011.

Rondonuwu IA, Haroen H, Wantania FE. 2016. Profil Kanker Payudara di RSUP Prof. Dr. R.D. Kandou Manado tahun 2013-2014. Jurnal e-Clinic (eCl) Volume 4 No 1, Januari-Juni 2016.

Tfayli A, Temraz S, Mrad RA, Shamseddine A. 2010. Breast Cancer In Low-And Middle-Income Countries : An Emerging And Challenging Epidemic. Journal of oncology Vol 490631, 5.

Vydelingum, NA. 2004. Economic Costs of Cancer Health Disparities In E. Taylor, ed Economic Costs of Cancer Health Disparities. US Departement of Health and Human Services.

Downloads

Published

2022-12-07

How to Cite

Manawan, F., & Timburas, M. W. (2022). ANALISIS KESESUAIAN BIAYA RIIL PASIEN KANKER PAYUDARA PESERTA JKN NON-PBI DENGAN TARIF INA-CBG’s DI RSUP PROF DR KANDOU MANADO. PHARMACON, 11(3), 1523–1529. https://doi.org/10.35799/pha.11.2022.40472

Issue

Vol. 11 No. 3 (2022): PHARMACON

Section

Articles

License

Copyright (c) 2022 PHARMACON

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)